Mostrar el registro sencillo del ítem
dc.contributor.author
Christensen, Jon
dc.contributor.author
El-Gebali, Sara
dc.contributor.author
Natoli, Manuela
dc.contributor.author
Sengstag, Thierry
dc.contributor.author
Delorenzi, Mauro
dc.contributor.author
Bentz, Sussane
dc.contributor.author
Bouzourene, Hanifa
dc.contributor.author
Rumbo, Martín
dc.contributor.author
Felsani, Armando
dc.contributor.author
Siissalo, Sanna
dc.contributor.author
Hirvonen, Jouni
dc.contributor.author
Vila, Maya R.
dc.contributor.author
Saletti, Piercarlo
dc.contributor.author
Aguet, Michel
dc.contributor.author
Anderle, Pascale
dc.date.available
2019-07-29T23:08:55Z
dc.date.issued
2012-06
dc.identifier.citation
Christensen, Jon; El-Gebali, Sara; Natoli, Manuela; Sengstag, Thierry; Delorenzi, Mauro; et al.; Defining new criteria for selection of cell-based intestinal models using publicly available databases; BioMed Central; BMC Genomics; 13; 1; 6-2012; 274-279
dc.identifier.issn
1471-2164
dc.identifier.uri
http://hdl.handle.net/11336/80546
dc.description.abstract
Background: The criteria for choosing relevant cell lines among a vast panel of available intestinal-derived lines exhibiting a wide range of functional properties are still ill-defined. The objective of this study was, therefore, to establish objective criteria for choosing relevant cell lines to assess their appropriateness as tumor models as well as for drug absorption studies.Results: We made use of publicly available expression signatures and cell based functional assays to delineate differences between various intestinal colon carcinoma cell lines and normal intestinal epithelium. We have compared a panel of intestinal cell lines with patient-derived normal and tumor epithelium and classified them according to traits relating to oncogenic pathway activity, epithelial-mesenchymal transition (EMT) and stemness, migratory properties, proliferative activity, transporter expression profiles and chemosensitivity. For example, SW480 represent an EMT-high, migratory phenotype and scored highest in terms of signatures associated to worse overall survival and higher risk of recurrence based on patient derived databases. On the other hand, differentiated HT29 and T84 cells showed gene expression patterns closest to tumor bulk derived cells. Regarding drug absorption, we confirmed that differentiated Caco-2 cells are the model of choice for active uptake studies in the small intestine. Regarding chemosensitivity we were unable to confirm a recently proposed association of chemo-resistance with EMT traits. However, a novel signature was identified through mining of NCI60 GI50 values that allowed to rank the panel of intestinal cell lines according to their drug responsiveness to commonly used chemotherapeutics.Conclusions: This study presents a straightforward strategy to exploit publicly available gene expression data to guide the choice of cell-based models. While this approach does not overcome the major limitations of such models, introducing a rank order of selected features may allow selecting model cell lines that are more adapted and pertinent to the addressed biological question.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
BioMed Central
dc.rights
info:eu-repo/semantics/openAccess
dc.rights.uri
https://creativecommons.org/licenses/by/2.5/ar/
dc.subject
Cell Lines
dc.subject
Chemosensitivity
dc.subject
Colon Cancer
dc.subject
Epithelial-Mesenchymal Transition
dc.subject
Genomic Profiling
dc.subject
Intestine
dc.subject
Malignant Traits
dc.subject.classification
Bioquímica y Biología Molecular
dc.subject.classification
Ciencias Biológicas
dc.subject.classification
CIENCIAS NATURALES Y EXACTAS
dc.title
Defining new criteria for selection of cell-based intestinal models using publicly available databases
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2019-07-04T18:14:54Z
dc.journal.volume
13
dc.journal.number
1
dc.journal.pagination
274-279
dc.journal.pais
Reino Unido
dc.journal.ciudad
Londres
dc.description.fil
Fil: Christensen, Jon. University of Freiburg; Alemania
dc.description.fil
Fil: El-Gebali, Sara. University of Bern; Suiza
dc.description.fil
Fil: Natoli, Manuela. Consiglio Nazionale delle Ricerche; Italia. Istituto di Biologia Cellulare e Neurobiologia; Italia
dc.description.fil
Fil: Sengstag, Thierry. Omics Science Center; Japón. RIKEN Yokohama Institute; Japón
dc.description.fil
Fil: Delorenzi, Mauro. Swiss Institute of Bioinformatics; Suiza. École Polytechnique Fédérale de Lausanne; Suiza
dc.description.fil
Fil: Bentz, Sussane. University of Bern; Suiza
dc.description.fil
Fil: Bouzourene, Hanifa. Centre Hospitalier et Universitaire Vaudois.
Institute of Pathology of Lausanne; Suiza
dc.description.fil
Fil: Rumbo, Martín. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata; Argentina. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Departamento de Ciencias Biológicas. Laboratorio de Investigaciones del Sistema Inmune; Argentina
dc.description.fil
Fil: Felsani, Armando. Consiglio Nazionale delle Ricerche; Italia. Istituto di Biologia Cellulare e Neurobiologia; Italia
dc.description.fil
Fil: Siissalo, Sanna. University of Helsinski; Finlandia
dc.description.fil
Fil: Hirvonen, Jouni. University of Helsinski; Finlandia
dc.description.fil
Fil: Vila, Maya R.. Centro Tecnológico LEITAT; España
dc.description.fil
Fil: Saletti, Piercarlo. Ospedale Regionale di Lugano; Italia
dc.description.fil
Fil: Aguet, Michel. École Polytechnique Fédérale de Lausanne; Suiza. Swiss Institute of Bioinformatics; Suiza
dc.description.fil
Fil: Anderle, Pascale. University of Bern; Suiza. Swiss Institute of Bioinformatics; Suiza. École Polytechnique Fédérale de Lausanne; Suiza
dc.journal.title
BMC Genomics
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1186/1471-2164-13-274
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://bmcgenomics.biomedcentral.com/articles/10.1186/1471-2164-13-274
Archivos asociados